In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage*; D003523:Cycloserine / Q000494:pharmacology; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000494:pharmacology; D011718:Pyrazinamide / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013828:Thioacetazone / Q000494:pharmacology; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin